---
aliases:
- (Mitterling et al., 2025)
author: Mitterling, Thomas and Riffert, Vivien and Heimel, Sophie and Leibetseder,
  Annette and Kaindlstorfer, Andreas and Heidbreder, Anna and Pichler, Josef and Von
  Oertzen, Tim J.
citekey: mitterling2025SleepDisturbanceStructured
date_added: '2025-03-23'
doi: 10.1016/j.sleep.2024.11.033
journal: Sleep Medicine
title: 'Beyond Sleep Disturbance: Structured Analysis of Sleep Habits, Chronotype
  and Sleep Disorders in Adults with Glioma. A Cross-Sectional Exploratory Study'
year: '2025'

---
# Beyond Sleep Disturbance: Structured Analysis of Sleep Habits, Chronotype and Sleep Disorders in Adults with Glioma. A Cross-Sectional Exploratory Study
- [PDF Link](zotero://open-pdf/library/items/D47G5HBU)

Citation: [@mitterling2025SleepDisturbanceStructured]

***
# TL;DR (Summary)
- 22.8% of glioma patients reported poor sleep quality (PSQI >5).
- 17.7% of patients experienced excessive daytime sleepiness (ESS >10).
- 43% of patients had at least a moderate risk of obstructive sleep apnea (STOPBANG ≥3).
- The predominant chronotype was moderate morning type (54.4%).
- 8.8% of patients met criteria for Restless Legs Syndrome (RLS).
- 11% of patients fulfilled criteria for probable REM Sleep Behavior Disorder (RBD).
- First study to comprehensively evaluate sleep disorders, chronotype, and sleep-related motor phenomena in adult glioma patients.
- Utilized a broad spectrum of validated scales to assess various sleep disorders, providing a detailed analysis beyond general sleep disturbance.
- Authors suggest that the low burden of insomnia in glioma patients might be due to the time elapsed since tumor diagnosis and surgery.
- They emphasize the need for a differentiated strategy in evaluating sleep disruption in glioma patients, considering the complex association with tumor grade and localization.
- Future studies should include objective measures like polysomnography to confirm subjective findings and explore the influence of specific medications on sleep.
- Unlike previous studies, this research found a lower prevalence of insomnia in glioma patients, suggesting a different etiology for sleep disturbances.
- The study highlights the importance of considering tumor localization and grade when assessing sleep disorders in glioma patients.
- It provides guidance for screening and evaluating sleep disorders in brain tumor patients, where general recommendations are currently lacking.

# 中文摘要 (TL;DR)
- 22.8% 的膠質瘤患者報告睡眠質量差（PSQI >5）。
- 17.7% 的患者出現過度白天嗜睡（ESS >10）。
- 43% 的患者至少有中度阻塞性睡眠呼吸暫停的風險（STOPBANG ≥3）。
- 主要的晝夜節律類型是中度早晨型（54.4%）。
- 8.8% 的患者符合不安腿綜合症（RLS）的標準。
- 11% 的患者符合可能的快速眼動睡眠行為障礙（RBD）的標準。
- 首次全面評估成人膠質瘤患者中的睡眠障礙、晝夜節律類型和睡眠相關運動現象的研究。
- 使用廣泛的經驗證量表來評估各種睡眠障礙，提供了超出一般睡眠障礙的詳細分析。
- 作者認為膠質瘤患者中失眠負擔低可能是由於自腫瘤診斷和手術以來的時間經過。
- 他們強調在評估膠質瘤患者的睡眠障礙時，需要考慮腫瘤等級和位置的複雜關聯，採取差異化的策略。
- 未來的研究應該包括多導睡眠圖等客觀措施來確認主觀發現，並探討特定藥物對睡眠的影響。
- 與之前的研究不同，本研究發現膠質瘤患者中失眠的患病率較低，表明睡眠障礙的病因可能不同。
- 該研究強調在評估膠質瘤患者的睡眠障礙時，應考慮腫瘤位置和等級的重要性。
- 它為篩查和評估腦腫瘤患者的睡眠障礙提供了指導，目前這方面的一般建議尚缺失。
